Filipa P. Mendes

Bobadela, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration.

Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration.

Journal: Chemical science

Published: January 01, 2026

Aquaporin-3 and aquaporin-5 impact the development of pancreatic ductal adenocarcinoma spheroids.

Aquaporin-3 and aquaporin-5 impact the development of pancreatic ductal adenocarcinoma spheroids.

Journal: FEBS open bio

Published: December 18, 2025

Fe/57Fe-Metallacarboranes with Radiosensitizing Potential in Breast Cancer Cell Models: Comparative Study Between High- (60Co) and Low-Energy (57Co) Gamma Radiation Sources.

Fe/57Fe-Metallacarboranes with Radiosensitizing Potential in Breast Cancer Cell Models: Comparative Study Between High- (60Co) and Low-Energy (57Co) Gamma Radiation Sources.

Journal: Pharmaceutics

Published: December 17, 2025

Yeast NatB Regulates Cell Death of Bax-Expressing Cells.

Yeast NatB Regulates Cell Death of Bax-Expressing Cells.

Journal: Biomolecules

Published: October 31, 2025

N-Heterocyclic Carbenes as Ligands to 198Au(I)-Radiolabeled Compounds: A New Platform for Radiopharmaceutical Design.

N-Heterocyclic Carbenes as Ligands to 198Au(I)-Radiolabeled Compounds: A New Platform for Radiopharmaceutical Design.

Journal: Journal of medicinal chemistry

Published: August 13, 2025

Assessment of Carrier-Free Metallacarboranes for Targeted Radiation Therapies PBFT and BNCT: Comparative Cellular Effects and Dosimetry Studies with [o-FESAN]- in Breast Cancer Cells.

Assessment of Carrier-Free Metallacarboranes for Targeted Radiation Therapies PBFT and BNCT: Comparative Cellular Effects and Dosimetry Studies with [o-FESAN]- in Breast Cancer Cells.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 22, 2025

GRPR-targeted gold nanoparticles as selective radiotherapy enhancers in glioblastoma.

GRPR-targeted gold nanoparticles as selective radiotherapy enhancers in glioblastoma.

Journal: Physics in medicine and biology

Published: March 21, 2025

Recommendations for reporting preclinical radiobiological studies in targeted radionuclide therapy.

Recommendations for reporting preclinical radiobiological studies in targeted radionuclide therapy.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 24, 2025

Mitochondria-tropic radioconjugates to enhance the therapeutic potential of terbium-161.

Mitochondria-tropic radioconjugates to enhance the therapeutic potential of terbium-161.

Journal: EJNMMI radiopharmacy and chemistry

Published: January 07, 2025

Harnessing the power of biosensors for environmental monitoring of pesticides in water.

Harnessing the power of biosensors for environmental monitoring of pesticides in water.

Journal: Applied microbiology and biotechnology

Published: December 29, 2024

Synthesis and Evaluation of Cytotoxic Activity of RuCp(II) Complexes Bearing (Iso)nicotinic Acid Based Ligands.

Synthesis and Evaluation of Cytotoxic Activity of RuCp(II) Complexes Bearing (Iso)nicotinic Acid Based Ligands.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 21, 2024

Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles.

Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles.

Journal: Pharmaceutics

Published: June 05, 2024

Showing 1-12 of 66

Last Updated: 09/26/2026